Amanote Research

Amanote Research

    RegisterSign In

Antibody-Drug Conjugates in Bladder Cancer

Bladder Cancer - Netherlands
doi 10.3233/blc-180169
Full Text
Open PDF
Abstract

Available in full text

Categories
OncologyUrology
Date

July 30, 2018

Authors
Panagiotis J. VlachostergiosChristopher D. JakubowskiMuhammad J. NiazAileen LeeCharlene ThomasAmy L. HackettPriyanka PatelNaureen RashidScott T. Tagawa
Publisher

IOS Press


Related search

Site-Specific Antibody Drug Conjugates for Cancer Therapy

mAbs
AllergyImmunology
2013English

Application of Radionuclides and Antibody-Drug Conjugates to Target Cancer

Cancer Studies and Molecular Medicine - Open Journal
2014English

The Promise of Antibody–Drug Conjugates

New England Journal of Medicine
Medicine
2012English

Antibody – Drug Conjugates (ADC) – Drug Discovery Today: Technologies

Drug Discovery Today: Technologies
BiotechnologyDrug DiscoveryMolecular Medicine
2018English

Studies on Antibody-Anticancer Drug Conjugates

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1983English

Antibody-Dm1 Conjugates as Cancer Therapeutics

Cancer Letters
Cancer ResearchOncology
2011English

Bispecifics and Antibody–drug Conjugates: A Positive Synergy

Drug Discovery Today: Technologies
BiotechnologyDrug DiscoveryMolecular Medicine
2018English

Monodisperse Polysarcosine-Based Highly-Loaded Antibody-Drug Conjugates

Chemical Science
Chemistry
2019English

Antibody–drug Conjugates: Using Monoclonal Antibodies for Delivery of Cytotoxic Payloads to Cancer Cells

Therapeutic Delivery
Pharmaceutical Science
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy